CANNABIS SATIVA, INC. : Change in Directors or Principal Officers (form 8-K)
November 23, 2022 at 04:00 pm EST
Share
ITEM 5.02 Departure of Directors or Certain Officers.
As reported in the Company's Form 8-K filed with the Securities and Exchange
Commission on November 3, 2022, on October 28, 2022, Brad E. Herr resigned his
position as principal financial and accounting officer of the Company. On
November 14, 2022, the board of directors elected the Company's Chief Executive
Officer, David Tobias, to also serve as the principal financial and accounting
officer of the Company. At this time, Mr. Tobias will not be paid any additional
compensation for his service as the principal financial and accounting officer
but arrangements for more compensation may be made in the future. The business
resume of Mr. Tobias is set forth on page 21 of the Company's Form 10-K filed
with the Securities and Exchange Commission on April 14, 2022, which resume is
hereby incorporated herein by reference.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
